The basic similarities with a few massive blockbus
Post# of 142859
![Avatar](/images/ProfileImages/883511230_63069_treesquare.jpg)
LERONLIMAB is a monoclonal antibody that binds to the CCR5 receptor, blocking ligands and starts a cascade of innate immune response and modulation of various sorts.
KEYTRUDA is a monoclonal antibody that binds to the PD-1 receptor, blocking ligands PD‑L1 and PD‑L2, from interacting with PD-1 to help restore T-cell response and immune response
OPDIVO® (nivolumab) and YERVOY® (ipilimumab) also binds with PD-L1 receptor, blocking ligands, and starts immune response.
Safety is key, LL is wildly safe
<<KEYTRUDA can lead to death. >>
<<OPDIVO and YERVOY can lead to death. >>
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)